|
Distribution of International Classification of Primary Care (ICPC) codes among patients with ≥ 1 code (N = 57,041) |
||||
| ICPC codes |
Disease entity |
Reasons for exclusion |
number |
% |
|
|
||||
| K87 |
Complicated hypertension |
The presence of unknown complications may favor or preclude prescription of a particular drug class |
3310 |
5.8% |
| T90 |
Diabetes Mellitus |
Favors the choice of ACEIs |
15560 |
27.3% |
| T901 |
Impaired glucose tolerance |
353 |
0.6% |
|
| T92 |
Gout |
Contraindication of thiazide diuretics |
635 |
1.1% |
| T93 |
Lipid disorders |
Favor the exclusion of thiazide diuretics and β-blockers |
1186 |
2.1% |
| K90 |
Stroke/cerebrovascular accident |
Favor the choice of β-blockers |
1920 |
3.4% |
| K91 |
Cerebrovascular disease |
130 |
0.2% |
|
| K74 |
Ischemic Heart Disease with angina |
348 |
0.6% |
|
| K76 |
Ischemic Heart Disease without angina |
1099 |
1.9% |
|
| K75 |
Acute Myocardial Infarction |
213 |
0.4% |
|
| K77 |
Heart Failure |
Favor the choice of ACEIs |
794 |
1.4% |
| K84 |
Heart Disease, other |
Favor the choice of β-blockers or ACEIs |
168 |
0.3% |
| K99 |
Cardiovascular disease, other |
113 |
0.2% |
|
| R79 |
Chronic Bronchitis |
Contraindication of β-blockers |
436 |
0.8% |
| R95 |
Chronic Obstructive Pulmonary Disease |
2199 |
3.9% |
|
| R96 |
Asthma |
1083 |
1.9% |
|
| U14 |
Kidney symptoms/complaints |
Either favor or a contraindication of ACEIs |
312 |
0.5% |
| U88 |
Glomerulonephritis/nephrosis |
36 |
0.1% |
|
| Y85 |
Benign Prostatic Hypertrophy |
Favor the prescription of α-blockers |
2917 |
5.1% |
| U78 |
Benign Neoplasm Urinary Tract |
30 |
0.1% |
|
| Y79 |
Benign/unspecified neoplasm, male genital |
1 |
0.0% |
|
|
(ACEIs: Angiotensin Converting Enzyme Inhibitors. There were a total of 46,859 patients (82.1%) Apart from K86 these conditions are influencing factors for antihypertensive drug prescription and were named "exclusion codes" | ||||
Wong et al. BMC Health Services Research 2008 8:138 doi:10.1186/1472-6963-8-138 |
||||